Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Transplant ; 16(4): 280-4, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12099984

RESUMO

BACKGROUND: With evolving medical techniques and post-operative care, the quality of life after cardiac transplantation is improving over the recent years. However, the need for continuous immunosuppressive therapy may result in restrictions from some social and recreational activities, including traveling. The aim of this study was to analyze traveling activities and complications in a large cohort of heart transplant recipients, with the intention to develop adequate safety and behavioral guidelines. METHODS: Using a standardized questionnaire, 103 consecutive patients (pts) were asked to report about time and destination of their traveling activities, predominant activities, as well as potential travel-related complications. Documented rejection episodes as well as laboratory data are listed. RESULTS: Feedback was 97% (of 103 pts asked). Out of 100 pts who responded, [82 males, 18 females, mean age 52.3 +/- 12.4 yr, 6.9 +/- 3.8 yr post-heart transplantation (HTX)] 95 reported on traveling activities (95%). Concomitant disease was present in form of diabetes (n=8), renal insufficiency (n=5) and cardiac allograft vasculopathy (n=12). Mean cumulative traveling time was 120 +/- 125 d (3-560 d). Except from domestic journeys, 79 pts chose destinations within Europe, and 29 to overseas countries. Complications were reported by 15 of 95 pts (15.8%), being mostly small accidents and febrile episodes. Rejection episodes or other life threatening events were not observed. There was no significant correlation between observed complications and gender, age, time post-HTX, immunosuppression or comorbidities. CONCLUSIONS: Traveling after HTX appears to be safe and favorably improves quality of life, if certain precautions are met.


Assuntos
Transplante de Coração , Viagem , Adulto , Estudos de Coortes , Comorbidade , Feminino , Transplante de Coração/efeitos adversos , Humanos , Imunossupressores/administração & dosagem , Masculino , Pessoa de Meia-Idade , Qualidade de Vida , Inquéritos e Questionários , Fatores de Tempo , Viagem/estatística & dados numéricos
2.
Artigo em Alemão | MEDLINE | ID: mdl-9480164

RESUMO

Ten years of quality control in routine have led to a standardized platelet concentrate (PC). Mean parameters of the preparations are in the range of pH 6.7-7.3, (1.0-1.5) x 10(9)/ml platelet concentration, 80 x 10(9) platelets/PC and 2 x 10(7) leukocytes/PC. To judge the function of PCs, three methods were compared: the morphologic score, platelet aggregation tests, and the hypotonic shock reaction. The result is: The hypotonic shock reaction is a simple, well reproducible and sensitive method to judge the cell integrity.


Assuntos
Plaquetas , Preservação de Sangue/normas , Agregação Plaquetária , Plaquetas/citologia , Plaquetas/fisiologia , Humanos , Soluções Hipotônicas , Leucócitos , Controle de Qualidade , Reprodutibilidade dos Testes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...